# Generation of Schlafen 8-Specific Antibodies

**Authors:** Juan Carlos Silva-Espinoza, Mauricio I. Rodriguez Rodriguez, Claire Eunise Perucho, Brian A. Terrazas, Carlos Valenzuela, Stephany Palos Vargas, Andrea Carlin, Diana L. Prospero, Giulio Francia, Manuel Llano

PMC · DOI: 10.3390/antib15010016 · Antibodies · 2026-02-21

## TL;DR

This paper describes the development of specific antibodies for the Schlafen 8 protein, enabling better study of its role in mice.

## Contribution

The study introduces a novel method to generate highly specific antibodies for SLFN8 using a surface-exposed peptide.

## Key findings

- The anti-SLFN8 antibody was validated across multiple immunodetection techniques.
- Hybridomas producing SLFN8-specific IgG antibodies were successfully generated.
- The identified peptide is highly immunogenic and distinguishes SLFN8 from SLFN9.

## Abstract

Background/Objectives: Schlafen (SLFN) 8 and SLFN9 are mouse members of the Schlafen protein family, believed to have arisen through a gene duplication event. The physiological roles of these proteins remain poorly defined, in part due to the absence of reliable, commercially available antibodies for their detection. Methods: To develop specific antibodies, we performed an amino acid sequence alignment of these proteins and identified a thirteen amino acids long peptide predicted by AlphaFold modeling and hydropathicity analysis to be surface-exposed in both SLFN proteins. The SLFN8 peptide was conjugated to KLH and used to immunize mice, employing Poly(I:C) as an adjuvant. Results: We verified the anti-SLFN8 antibody specificity in mouse tissues, engineered human cells, and recombinant proteins by different immunodetection techniques, including Western blotting, immunoprecipitation, immunohistochemistry, and ELISA. Furthermore, splenocytes from immunized mice were used to generate hybridomas that secreted IgG antibodies with SLFN8-peptide specificity, as assumed by ELISA. Conclusions: Our results demonstrate that the identified peptide is highly immunogenic and capable of eliciting antibodies that distinguish between these two exceedingly similar proteins in a broad group of immunodetection techniques.

## Linked entities

- **Genes:** Slfn8 (schlafen 8) [NCBI Gene 276950], Slfn9 (schlafen 9) [NCBI Gene 237886]
- **Proteins:** Slfn8 (schlafen 8), Slfn9 (schlafen 9)
- **Chemicals:** Poly(I:C) (PubChem CID 135618150)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Slfn8 (schlafen 8) [NCBI Gene 276950] {aka mSLFN8}, Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, Rpa1 (replication protein A1) [NCBI Gene 68275] {aka 5031405K23Rik, 70kDa, RF-A, RP-A, Rpa}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Slfn5 (schlafen 5) [NCBI Gene 327978], Entpd5 (ectonucleoside triphosphate diphosphohydrolase 5) [NCBI Gene 12499] {aka Cd39l4, ER-UDPase, NTPDase-5, NTPDase5, Pcph, mNTPase}, Slfnl1 (schlafen like 1) [NCBI Gene 194219] {aka 4933406A14Rik}, Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 20846] {aka 2010005J02Rik}, Slfn14 (schlafen 14) [NCBI Gene 237890] {aka Gm20, Slfn14-ps}, Slfn1 (schlafen 1) [NCBI Gene 20555], Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Slfn9 (schlafen 9) [NCBI Gene 237886] {aka 9830137M10Rik}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}
- **Diseases:** Infection (MESH:D007239), viral (MESH:D014777), experimental autoimmune encephalomyelitis (MESH:D004681), cancer (MESH:D009369), injury to (MESH:D014947), autoimmune inflammation (MESH:D007249), oncogenesis (MESH:D063646), autoimmune (MESH:D001327)
- **Chemicals:** bicarbonate (MESH:D001639), penicillin (MESH:D010406), hematoxylin (MESH:D006416), H&amp;E (MESH:D006371), Dulbecco's modified Eagle's medium (-), hydrogen peroxide (MESH:D006861), formalin (MESH:D005557), PVDF (MESH:C024865), pepstatin A (MESH:C031375), 3,3'-diaminobenzidine (MESH:D015100), eosin (MESH:D004801), PBS (MESH:D007854), Tween 20 (MESH:D011136), sucrose (MESH:D013395), citrate (MESH:D019343), BCA (MESH:C047117), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), Triton X-100 (MESH:D017830), EDTA (MESH:D004492), Poly(I:C) (MESH:D011070), PEI (MESH:D011094), xylene (MESH:D014992), carbonate (MESH:D002254), NaCl (MESH:D012965), MgCl2 (MESH:D015636), paraffin (MESH:D010232), ethanol (MESH:D000431), acrylamide (MESH:D020106), SDS (MESH:D012967), Laemmli buffer (MESH:C088816), DTT (MESH:D004229), Ponceau (MESH:C032756), MG132 (MESH:C072553)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], West Nile virus (no rank) [taxon 11082], Cytomegalovirus (genus) [taxon 10358], Human betaherpesvirus 5 (no rank) [taxon 10359], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Cell lines:** BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), E. coli — Mus musculus (Mouse), Hybridoma (CVCL_C5CR), Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059), SP2/0 — Mus musculus (Mouse), Mouse multiple myeloma, Cancer cell line (CVCL_2199), Rosetta (DE3 — Mus musculus (Mouse), Hybridoma (CVCL_B7HM), NIH/3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938254/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938254/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938254/full.md

---
Source: https://tomesphere.com/paper/PMC12938254